SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031352
Filing Date
2024-08-12
Accepted
2024-08-12 17:13:25
Documents
60
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1083652
2 ex31-1.htm EX-31.1 11518
3 ex31-2.htm EX-31.2 11613
4 ex32-1.htm EX-32.1 9611
  Complete submission text file 0001493152-24-031352.txt   5139768

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE envb-20240630.xsd EX-101.SCH 40348
6 XBRL CALCULATION FILE envb-20240630_cal.xml EX-101.CAL 53180
7 XBRL DEFINITION FILE envb-20240630_def.xml EX-101.DEF 131838
8 XBRL LABEL FILE envb-20240630_lab.xml EX-101.LAB 383019
9 XBRL PRESENTATION FILE envb-20240630_pre.xml EX-101.PRE 284709
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 738402
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 241197905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)